New genetic discovery could lead to treatment for PSP
In The Conversation, Dr. Joe Abisambra details the first evidence linking key proteins in the development of progressive supranuclear palsy.
Posted in
The Conversation
Meth inflames and stimulates your brain through similar pathways
In The Conversation, Drs. Habibeh Khoshbouei and Marcelo Febo discuss their new study paving the way to test immune-modulating medicines as a potential tool to break the cycle of meth addiction.
COVID-19 mRNA vaccines could unlock the next revolution in cancer treatment – new research
In The Conversation, Christiano Marconi discusses a new study in Nature finding that the COVID-19 mRNA vaccine sparks an immune response to fight cancer.
Yes, ADHD diagnoses are rising, but that doesn’t mean it’s overdiagnosed
In The Conversation, Dr. Carol Mathews discusses the trend of rising ADHD diagnoses and what this means.
Researchers uncovered hundreds of genes linked to OCD, providing clues about how it changes the brain − new research
In The Conversation, Dr. Carol Mathews explains her new study in Nature Genetics shedding light on the genetics of OCD.
A neuroscientist explains the science of pain
In The Conversation's Curious Kids series, Dr. Yenisel Cruz-Almeida explains pain, how it travels, and why it's needed as a warning signal.
Brain inflammation may be the reason behind muscle fatigue after infection and injury
In The Conversation, Dr. Diego Rincon-Limas discusses the role brain inflammation may play in muscle fatigue in cases of long COVID, Alzheimer's, or E. coli infections
Are older adults more vulnerable to scams?
In The Conversation, Drs. Natalie Ebner and Didem Pehlivanoglu discuss the factors that shape vulnerability to scams in older adults.
Brain cancer in children is notoriously hard to treat – a new mRNA cancer vaccine triggers an attack from within
In The Conversation Drs. John Ligon and Christina von Roemeling discuss new paper they co-authored in the journal Cell.
Newly discovered genetic variant that causes Parkinson’s disease clarifies why the condition develops and how to halt it
In The Conversation, Dr. Matthew Farrer discusses his team's new paper published in The Lancet Neurology.
